Diagnostic Problems in Breast Pathology

Diagnostic Problems in Breast Pathology

Volumn , Issue , 2009, Pages

  Koerner, Frederick C ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85013688595     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-2612-9.X0001-7     Document Type: Book

References (180)

1. Mills SE Sternberg's Histology for Pathologists 2006, Lippincott Williams & Wilkins, Philadelphia. 3rd.
2. Potten CS, Watson RJ, Williams GT, et al. The effect of age and menstrual cycle upon proliferative activity of the normal human breast. Br J Cancer 1988, 58:163-170.
3. Russo J, Rivera R, Russo IH Influence of age and parity on the development of the human breast. Breast Cancer Res Treat 1992, 23:211-218.
4. Azzopardi JG: Problems in Breast Pathology. (Major Problems in Pathology, vol 11.) London, WB Saunders, 1979.
5. Page DL, Anderson TJ Diagnostic Histopathology of the Breast 1987, Churchill Livingstone, Edinburgh.
6. Azzopardi JG: Problems in Breast Pathology. (Major Problems in Pathology, vol 11). London, WB Saunders, 1979.
7. Abdel-Fatah TM, Powe DG, Hodi Z, et al. High frequency coexistence of columnar cell lesion, lobular neoplasia, and low-grade ductal carcinoma in situ with invasive tubular carcinoma and invasive lobular carcinoma. Am J Surg Pathol 2007, 31:417-426.
8. Azzopardi JG: Problems in Breast Pathology. (Major Problems in Pathology, vol 11). London, WB Saunders, 1979.
9. Azzopardi JG Benign and malignant proliferative epithelial lesion of the breast: a review. Eur J Cancer Clin Oncol 1983, 19:1717-1720.
10. Bodian CA, Perzin KH, Lattes R, et al. Prognostic significance of benign proliferative breast disease. Cancer 1993, 71:3896-3907.
11. Boecker W, Buerger H, Schmitz K, et al. Ductal epithelial proliferations of the breast: A biologic continuum? Comparative genomic hybridization and high-molecular-weight cytokeratin expression patterns. J Pathol 2001, 195:415-421.
12. Boecker W, Moll R, Dervan P, et al. Usual ductal hyperplasia of the breast is a committed stem (progenitor) cell lesion distinct from atypical ductal hyperplasia and ductal carcinoma in situ. J Pathol 2002, 198:458-467.
13. Dabbs DJ, Carter G, Fudge M Molecular alterations in columnar cell lesions of the breast. Mod Pathol 2006, 19:344-349.
14. Dupont WD, Page DL Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 1985, 312:146-151.
15. Eusebi V, Feudale E, Foschini MP Long-term follow-up of in situ carcinoma of the breast with special emphasis on clinging carcinoma. Semin Diagn Pathol 1994, 11:223-235.
16. Leibl S, Regitnig P, Moinfar F Flat epithelial atypia (DIN 1a, atypical columnar cell change): An underdiagnosed entity very frequently coexisting with lobular neoplasia. Histopathology 2007, 50:859-865.
17. London SJ, Connolly JL, Schnitt SJ, et al. A prospective study of benign breast disease and the risk of breast cancer. JAMA 1992, 267:941-944.
18. McDivitt RW, Holleb AI, Foote FW Prior breast disease in patient treated for papillary carcinoma. Arch Pathol 1968, 85:117-124.
19. McDivitt RW, Stevens JA, Lee NC, et al. Histologic types of benign breast disease and the risk for breast cancer. The cancer and steroid hormone study group. Cancer 1992, 69:1408-1414.
20. McDivitt RW, Stewart FW, Berg JW Tumors of the Breast 1950, Armed Forces Institute of Pathology, Washington, DC.
21. Moinfar F, Man YG, Bratthauer GL, et al. Genetic abnormalities in mammary ductal intraepithelial neoplasia-flat type ('clinging ductal carcinoma in situ'): A simulator of normal mammary epithelium. Cancer 2000, 88:2072-2081.
22. Oyama T, Maluf H, Koerner F Pathologic findings after therapeutic irradiation of mammary tissues and carcinomas. Anat Pathol 1998, 3:181-193.
23. Otterbach F, Bánkfalvi A, Bergner S, et al. Cytokeratin 5/6 immunohistochemistry assists the differential diagnosis of atypical proliferations of the breast. Histopathology 2000, 37:232-240.
24. Page DL, Anderson TJ Diagnostic Histopathology of the Breast 1987, Churchill Livingstone, Edinburgh.
25. Raju U, Crissman JD, Zarbo RJ, et al. Epitheliosis of the breast: An immunohistochemical characterization and comparison to malignant intraductal proliferations of the breast. Am J Surg Pathol 1990, 14:939-947.
26. Schnitt SJ, Connolly JL, Harris JR, et al. Radiation-induced changes in the breast. Hum Pathol 1984, 15:545-550.
27. Simpson PT, Gale T, Reis-Filho, et al. Columnar cell lesions of the breast: The missing link in breast cancer progression? A morphologic and molecular analysis. Am J Surg Pathol 2005, 29:734-746.
28. Tavassoli FA, Norris HJ A comparison of the results of long-term follow-up for atypical intraductal hyperplasia and intraductal hyperplasia of the breast. Cancer 1990, 65:518-529.
29. Carter DJ, Rosen PP Atypical apocrine metaplasia in sclerosing lesions of the breast: A study of 51 patients. Mod Pathol 1991, 4:1-5.
30. Celis JE, Gromova I, Gromov P, et al. Molecular pathology of breast apocrine carcinomas: A protein expression signature specific for benign apocrine metaplasia. FEBS Lett 2006, 580:2935-2944.
31. Jones C, Damiani S, Wells D, et al. Molecular cytogenetic comparison of apocrine hyperplasia and apocrine carcinoma of the breast. Am J Pathol 2001, 158:207-214.
32. Leal C, Henrique R, Monteiro P, et al. Apocrine ductal carcinoma in situ of the breast: Histologic classification and expression of biologic markers. Hum Pathol 2001, 32:487-493.
33. O'Malley FP, Page DL, Nelson EH, et al. Ductal carcinoma in situ of the breast with apocrine cytology: Definition of a borderline category. Hum Pathol 1994, 25:164-168.
34. O'Malley FP, Bane AL The spectrum of apocrine lesions of the breast. Adv Anat Pathol 2004, 11:1-9.
35. Pagani A, Sapino A, Eusebi V, et al. PIP/GCDFP-15 gene expression and apocrine differentiation in carcinomas of the breast. Virchows Arch 1994, 425:459-465.
36. Page DL, Dupont WD, Jensen RA Papillary apocrine change of the breast: Associations with atypical hyperplasia and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 1996, 5:29-32.
37. Raju U, Zarbo RJ, Kubus J, et al. The histologic spectrum of apocrine breast proliferations: A comparative study of morphology and DNA content by image analysis. Hum Pathol 1993, 24:173-181.
38. Seidman JD, Ashton M, Lefkowitz M Atypical apocrine adenosis of the breast: A clinicopathologic study of 37 patients with 8.7-year follow-up. Cancer 1996, 77:2529-2537.
39. Selim AA, Ryan A, El-Ayat G, et al. Loss of heterozygosity and allelic imbalance in apocrine metaplasia of the breast: Microdissection microsatellite analysis. J Pathol 2002, 196:287-291.
40. Simpson PT, Reis-Filho JS, Gale T, et al. Molecular evolution of breast cancer. J Pathol 2005, 205:248-254.
41. Wells CA, El-Ayat GA Non-operative breast pathology: Apocrine lesions. J Clin Pathol 2007, 60:1313-1320.
42. Wells CA, McGregor IL, Makunura CN, et al. Apocrine adenosis: A precursor of aggressive breast cancer?. J Clin Pathol 1995, 48:737-742.
43. Zagorianakou P, Zagorianakou N, Stefanou D, et al. The enigmatic nature of apocrine breast lesions. Virchows Arch 2006, 448:525-531.
44. Fisher CJ, Millis RR A mucocele-like tumour of the breast associated with both atypical ductal hyperplasia and mucoid carcinoma. Histopathology 1992, 23:69-71.
45. Fisher ER, Palekar AS, Stoner F, et al. Mucocele-like lesions and mucinous carcinoma of the breast. Int J Surg Pathol 1994, 1:213-220.
46. Hamele-Bena D, Cranor ML, Rosen PP Mammary mucocele-like lesions (MLL): Benign and malignant. Am J Surg Pathol 1996, 20:1081-1085.
47. Komaki K, Sakamoto G, Sugano H, et al. The morphologic feature of mucinous leakage appearing in low papillary carcinoma of the breast. Hum Pathol 1991, 22:231-236.
48. Kulka J, Davies JD Mucocele-like tumours: More associations and possible ductal carcinoma in situ?. Histopathology 1993, 22:511-512.
49. Ro JY, Sneige N, Sahin AA, et al. Mucocele-like tumor of the breast associated with atypical ductal hyperplasia or mucinous carcinoma: A clinicopathologic study of seven cases. Arch Pathol Lab Med 1991, 115:137-140.
50. Rosen PP Mucocele-like tumors of the breast. Am J Surg Pathol 1986, 10:464-469.
51. Weaver MG, Abdul-Karim FW, Al-Kaisi N Mucinous lesions of the breast: A pathological continuum. Pathol Res Pract 1993, 189:873-876.
52. Abdel-Fatah TM, Powe DG, Hodi A, et al. High frequency coexistence of columnar cell lesion, lobular neoplasia, and low-grade ductal carcinoma in situ with invasive tubular carcinoma and invasive lobular carcinoma. Am J Surg Pathol 2007, 31:417-426.
53. Acs G, Lawton TJ, Rebbeck TR, et al. Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications. Am J Clin Pathol 2001, 115:85-98.
54. Bànkfalvi À, Terpe H-J, Breukelmann D, et al. Immunophenotypic and prognostic analysis of E-cadherin and β-catenin expression during breast carcinogenesis and tumour progression: A comparative study with CD44. Histopathology 1999, 34:25-34.
55. Bentz JS, Yassa N, Clayton F Pleomorphic lobular carcinoma of the breast: Clinicopathologic features of 12 cases. Mod Pathol 1998, 11:814-822.
56. Bratthauer GL, Tavassoli FA Lobular intraepithelial neoplasia: Previously unexplored aspects assessed in 775 cases and their clinical implications. Virchows Arch 2002, 440:134-138.
57. De Leeuw WJ, Berx G, Vos CB, et al. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ. J Pathol 1997, 183:404-411.
58. Fadare O, Dadmanesh F, Alvarado-Cabrero I, et al. Lobular intraepithelial neoplasia [lobular carcinoma in situ] with comedo-type necrosis: A clinicopathologic study of 18 cases. Am J Surg Pathol 2006, 30:1445-1453.
59. Fechner RE Lobular carcinoma in situ in sclerosing adenosis: A potential source of confusion with invasive carcinoma. Am J Surg Pathol 1981, 5:233-239.
60. Foote FW, Stewart FW Lobular carcinoma in situ: A rare form of mammary cancer. Am J Pathol 1941, 17:491-495.
61. Goldstein NS, Bassi D, Watts JC, et al. E-cadherin reactivity of 95 noninvasive ductal and lobular lesions of the breast: Implications for the interpretation of problematic lesions. Am J Clin Pathol 2001, 115:534-542.
62. Haagensen CD, Lane N, Lattes R, et al. Lobular neoplasia (so-called lobular carcinoma in situ) of the breast. Cancer 1978, 42:737-769.
63. Jacobs TW, Pliss N, Kouria G, et al. Carcinoma in situ of the breast with indeterminate features: Role of E-cadherin staining in categorization. Am J Surg Pathol 2001, 25:229-236.
64. Lerwill MF The evolution of lobular neoplasia. Adv Anat Pathol 2006, 13:157-165.
65. Lu YJ, Osin P, Lakhani SR, et al. Comparative genomic hybridization analysis of lobular carcinoma in situ and atypical lobular hyperplasia and potential roles for gains and losses of genetic material in breast neoplasia. Cancer Res 1998, 58:4721-4727.
66. Mastracci TL, Shadeo A, Colby SM, et al. Genomic alteration in lobular neoplasia: A microarray comparative genomic hybridization signature for early neoplastic proliferation in the breast. Genes Chromosomes Cancer 2006, 45:1007-1017.
67. Mastracci TL, Tjan S, Bane A, et al. E-cadherin alterations in atypical lobular hyperplasia and lobular carcinoma in situ of the breast. Mod Pathol 2005, 18:741-751.
68. Morandi L, Marucci G, Foschini MP, et al. Genetic similarities and differences between lobular in situ neoplasia (LN) and invasive lobular carcinoma of the breast. Virchows Arch 2006, 449:14-23.
69. Page DL, Kidd TE, Dupont WD, et al. Lobular neoplasia of the breast: Higher risk for subsequent invasive cancer predicted by more extensive disease. Hum Pathol 1991, 22:1232-1239.
70. Reis-Filho JS, Simpson PT, Jones C, et al. Pleomorphic lobular carcinoma in situ: Role of comprehensive molecular pathology in characterization of an entity. J Pathol 2005, 207:1-13.
71. Resetkova E, Albarracin C, Sneige N Collagenous spherulosis of breast: Morphologic study of 59 cases and review of the literature. Am J Surg Pathol 2006, 30:20-27.
72. Rosen PP, Lieberman PH, Braun DW, et al. Lobular carcinoma in situ of the breast: Detailed analysis of 99 patients with average follow-up of 24 years. Am J Surg Pathol 1978, 2:225-251.
73. Sgroi D, Koerner FC Involvement of collagenous spherulosis by lobular carcinoma in situ: Potential confusion with cribriform ductal carcinoma in situ. Am J Surg Pathol 1995, 19:1366-1370.
74. Vos CB, Cleton-Jansen AM, Berx G, et al. E-cadherin inactivation in lobular carcinoma in situ of the breast: An early event in tumorigenesis. Br J Cancer 1997, 76:1131-1133.
75. Azzopardi JG Problems in Breast Pathology. (Major Problems in Pathology, vol 11.) 1979, WB Saunders, London.
76. Kraus FT, Neubecker RD The differential diagnosis of papillary tumors of the breast. Cancer 1962, 15:444-455.
77. Murad TM, Contesso G, Mourisesse H Papillary tumors of large lactiferous ducts. Cancer 1981, 48:122-133.
78. Ohuchi N, Abe R, Kasai M Possible cancerous change of intraductal papillomas of the breast: A 3-D reconstruction study of 25 cases. Cancer 1984, 54:605-611.
79. Oyama T, Koerner FC Noninvasive papillary proliferations. Semin Diagn Pathol 2004, 21:32-41.
80. Sapino A, Botta G, Cassoni P, et al. Multiple papillomas of the breast: Morphologic findings and clinical evolution. Anat Pathol 1996, 1:205-218.
81. Azzopardi JG Problems in Breast Pathology. (Major Problems in Pathology, vol 11.) 1979, WB Saunders, London.
82. Ciatto S, Andreoli C, Cirillo A, et al. The risk of breast cancer subsequent to histologic diagnosis of benign intraductal papilloma: Follow-up study of 339 cases. Tumori 1991, 77:41-43.
83. Haagensen CD, Stout AP, Phillips JS The papillary neoplasms of the breast. I: Benign intraductal papilloma. Ann Surg 1951, 133:18-36.
84. Kraus FT, Neubecker RD The differential diagnosis of papillary tumors of the breast. Cancer 1962, 15:444-455.
85. Krieger N, Hiatt RA Risk of breast cancer after benign breast diseases: Variation by histologic type, degree of atypia, age at biopsy, and length of follow-up. Am J Epidemiol 1992, 135:619-631.
86. Murad TM, Contesso G, Mourisesse H Papillary tumors of large lactiferous ducts. Cancer 1981, 48:122-133.
87. Nagi C, Bleiweiss I, Jaffer S Epithelial displacement in breast lesions: A papillary phenomenon. Arch Pathol Lab Med 2005, 129:1465-1469.
88. Ohuchi N, Abe R, Kasai M Possible cancerous change of intraductal papillomas of the breast: A 3-D reconstruction study of 25 cases. Cancer 1984, 54:605-611.
89. Page DL, Salhany KE, Jensen RA, et al. Subsequent breast carcinoma risk after biopsy with atypia in a breast papilloma. Cancer 1996, 78:258-266.
90. Raju UB, Lee MW, Zarbo RJ, et al. Papillary neoplasia of the breast: Immunohistochemically defined myoepithelial cells in the diagnosis of benign and malignant papillary breast neoplasms. Mod Pathol 1989, 2:569-576.
91. Sapino A, Botta G, Cassoni P, et al. Multiple papillomas of the breast: Morphologic findings and clinical evolution. Anat Pathol 1996, 1:205-218.
92. Youngson BJ, Cranor M, Rosen PP Epithelial displacement in surgical breast specimens following needling procedures. Am J Surg Pathol 1994, 18:896-903.
93. Lefkowitz M, Lefkowitz W, Wargotz ES Intraductal (intracystic) papillary carcinoma of the breast and its variants: A clinicopathological study of 77 cases. Hum Pathol 1994, 25:802-809.
94. Gatchell FG, Dockerty MB, Clagett OT Intracystic carcinoma of the breast. Surg Gynecol Obstet 1958, 106:347-352.
95. Carter D, Orr SL, Merino MJ Intracystic papillary carcinoma of the breast after mastectomy, radiotherapy or excisional biopsy alone. Cancer 1983, 52:14-19.
96. Collins LC, Carlo VP, Hwang H, et al. Intracystic papillary carcinomas of the breast: A reevaluation using a panel of myoepithelial cell markers. Am J Surg Pathol 2006, 30:1002-1007.
97. Gatchell FG, Dockerty MB, Clagett OT Intracystic carcinoma of the breast. Surg Gynecol Obstet 1958, 106:347-352.
98. Hill CB, Yeh IT Myoepithelial cells staining patterns of papillary breast lesions: From intraductal papillomas to invasive papillary carcinomas. Am J Clin Pathol 2005, 123:36-44.
99. Leal C, Costa, Fonseca D, et al. Intracystic (encysted) papillary carcinoma of the breast: A clinical, pathological, and immunohistochemical study. Hum Pathol 1998, 29:1097-1104.
100. Lefkowitz M, Lefkowitz W, Wargotz ES Intraductal (intracystic) papillary carcinoma of the breast and its variants: A clinicopathological study of 77 cases. Hum Pathol 1994, 25:802-809.
101. Maluf HM, Koerner FC Solid papillary carcinoma of the breast: A form of intraductal carcinoma with endocrine differentiation frequently associated with mucinous carcinoma. Am J Surg Pathol 1995, 19:1237-1244.
102. Mulligan AM, O'Malley FP Metastatic potential of encapsulated (intracystic) papillary carcinoma of the breast: A report of 2 cases with axillary lymph nodes micrometastases. Int J Surg Pathol 2007, 15:143-147.
103. Tsang WY, Chan JK Endocrine ductal carcinoma in situ (E-DCIS) of the breast: A form of low-grade DCIS with distinctive clinicopathologic and biologic characteristics. Am J Surg Pathol 1996, 20:921-943.
104. Holland R, Hendriks JH, Verbeek AL, et al. Extent, distribution, and mammographic/histological correlations of breast ductal carcinoma in situ. Lancet 1990, 335:519-522.
105. Lagios MD, Margolin FR, Westdahl PR, et al. Mammographically detected duct carcinoma in situ: Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence. Cancer 1989, 63:618-624.
106. Fenoglio C, Lattes R Sclerosing papillary proliferations in the female breast: A benign lesion often mistaken for carcinoma. Cancer 1974, 33:691-700.
107. Rosen PP Subareolar sclerosing duct hyperplasia of the breast. Cancer 1987, 59:1927-1930.
108. Taylor HB, Norris HJ Well-differentiated carcinoma of the breast. Cancer 1970, 25:687-692.
109. Urban JA, Adair FE Sclerosing adenosis. Cancer 1949, 2:625-634.
110. Davies JD Neural invasion in benign mammary dysplasia. J Pathol 1973, 109:225-231.
111. Fechner RE Lobular carcinoma in situ in sclerosing adenosis: A potential source of confusion with invasive carcinoma. Am J Surg Pathol 1981, 5:233-239.
112. Jensen RA, Page DL, Dupont WD, et al. Invasive breast cancer risk in women with sclerosing adenosis. Cancer 1989, 64:1977-1983.
113. Lee KC, Chan JK, Gwi E Tubular adenosis of the breast: A distinctive benign lesion mimicking invasive carcinoma. Am J Surg Pathol 1996, 20:46-54.
114. Nielsen BB Adenosis tumour of the breast-a clinicopathological investigation of 27 cases. Histopathology 1987, 11:1259-1275.
115. Oberman HA, Markey BA Non-invasive carcinoma of the breast presenting in adenosis. Mod Pathol 1991, 4:31-35.
116. Taylor HB, Norris HJ Epithelial invasion of nerves in benign diseases of the breast. Cancer 1967, 20:2245-2249.
117. Andersen JA, Gram JB Radial scar in the female breast: A long-term follow-up study of 32 cases. Cancer 1984, 53:2557-2560.
118. Anderson TJ, Battersby S Radial scars of benign and malignant breasts: Comparative features and significance. J Pathol 1985, 147:23-32.
119. Fenoglio C, Lattes R Sclerosing papillary proliferations in the female breast: A benign lesion often mistaken for carcinoma. Cancer 1974, 33:691-700.
120. Fisher ER, Palekar AS, Kotwal N, et al. A nonencapsulated sclerosing lesion of the breast. Am J Clin Pathol 1979, 71:240-246.
121. Fisher ER, Palekar AS, Sass R, et al. Scar cancers: Pathologic findings from the National Surgical Adjuvant Breast Project (protocol No. 4) - IX. Breast Cancer Res Treat 1983, 3:39-59.
122. Hamperl H Strahlige narben und obliterierende mastopathie: Beiträge zur pathologischen histologie der mamma. XI. Virchows Arch A Pathol Anat Histol 1975, 369:55-68.
123. Jacobs TW, Byrne C, Colditz G, et al. Radial scars in benign breast-biopsy specimens and the risk of breast cancer. N Engl J Med 1999, 340:430-436.
124. Linell F, Ljungberg O, Andersson I Breast carcinoma: Aspects of early stage, progression and related problems. Acta Pathol Microbiol Scand Suppl 1980, 272:1-233.
125. Nielsen M, Christensen L, Andersen J Radial scars in women with breast cancer. Cancer 1987, 59:1019-1025.
126. Nielsen M, Jensen J, Andersen JA An autopsy study of radial scar in the female breast. Histopathology 1985, 9:287-295.
127. Rickert RR, Kalisher L, Hutter RV Indurative mastopathy: A benign sclerosing lesion of breast with elastosis which may simulate carcinoma. Cancer 1981, 47:561-571.
128. Sloane JP, Mayers MM Carcinoma and atypical hyperplasia in radial scars and complex sclerosing lesions: Importance of lesion size and patient age. Histopathology 1993, 23:225-231.
129. Taylor HB, Norris HJ Well-differentiated carcinoma of the breast. Cancer 1970, 25:687-692.
130. Abdel-Fatah TM, Powe DG, Hodi Z, et al. High frequency coexistence of columnar cell lesion, lobular neoplasia, and low-grade ductal carcinoma in situ with invasive tubular carcinoma and invasive lobular carcinoma. Am J Surg Pathol 2007, 31:417-426.
131. Carstens PHB, Greenberg RA, Francis D, et al. Tubular carcinoma of the breast: A long-term follow-up. Histopathology 1985, 9:271-280.
132. Cooper HS, Patchefsky AS, Krall RA Tubular carcinoma of the breast. Cancer 1978, 42:2334-2342.
133. Deos PH, Norris HJ Well-differentiated (tubular) carcinoma of the breast: A clinicopathologic study of 145 pure and mixed cases. Am J Clin Pathol 1982, 78:1-7.
134. Diaz NM, McDivitt RW, Wick MR Microglandular adenosis of the breast: An immunohistochemical comparison with tubular carcinoma. Arch Pathol Lab Med 1991, 115:578-582.
135. Fernandez-Aguilar S, Simon P, Buxant F, et al. Tubular carcinoma of the breast and associated intra-epithelial lesions: A comparative study with invasive low-grade ductal carcinoma. Virchows Arch 2005, 447:683-687.
136. Foschini MP, Pizzicannella G, Peterse JL, Eusebi V Adenomyoepithelioma of the breast associated with low-grade adenosquamous and sarcomatoid carcinoma. Virchows Arch 1995, 427:243-250.
137. Koenig C, Dadmanesh F, Bratthauer GL, et al. Carcinoma arising in microglandular adenosis: An immunohistochemical analysis of 20 intraepithelial and invasive neoplasms. Int J Surg Pathol 2000, 8:303-315.
138. McDivitt RW, Boyce W, Gersell D Tubular carcinoma of the breast: Clinical and pathological observations concerning 135 cases. Am J Surg Pathol 1982, 6:401-411.
139. Parl FF, Richardson LD The histologic and biologic spectrum of tubular carcinoma of the breast. Hum Pathol 1983, 14:694-698.
140. Rosen PP Microglandular adenosis: A benign lesion simulating invasive mammary carcinoma. Am J Surg Pathol 1983, 7:137-144.
141. Rosen PP, Ernsberger D Low-grade adenosquamous carcinoma: A variant of metaplastic mammary carcinoma. Am J Surg Pathol 1987, 11:351-358.
142. Stalsberg H, Hartmann WH The delimitation of tubular carcinoma of the breast. Hum Pathol 2000, 31:601-607.
143. Taylor HB, Norris HJ Well-differentiated carcinoma of the breast. Cancer 1970, 25:687-692.
144. Tavassoli FA, Norris HJ Microglandular adenosis of the breast: A clinicopathological study of 11 cases with ultrastructural observations. Am J Surg Pathol 1983, 7:731-737.
145. Van Hoeven KH, Drudis T, Cranor ML, et al. Low-grade adenosquamous carcinoma of the breast: A clinicopathologic study of 32 cases with ultrastructural analysis. Am J Surg Pathol 1993, 17:248-258.
146. Arrigoni MG, Dockerty MB, Judd ES The identification and treatment of mammary hamartoma. Surg Gynecol Obstet 1971, 133:577-582.
147. Azzopardi JG Problems in Breast Pathology. (Major Problems in Pathology, vol 11.) 1979, WB Saunders, London.
148. Carney JA, Toorkey BC Myxoid fibroadenoma and allied conditions (myxomatosis) of the breast: A heritable disorder with special associations including cardiac and cutaneous myxomas. Am J Surg Pathol 1991, 15:713-721.
149. Curran RC, Dodge OG Sarcoma of breast, with particular reference to its origin from fibroadenoma. J Clin Pathol 1962, 15:1-16.
150. Koerner FC, O'Connell JX Fibroadenoma: Morphological observations and a theory of pathogenesis. Pathol Annu 1994, 29:1-19.
151. Norris HJ, Taylor HB Relationship of histological features to behavior of cystosarcoma phyllodes: Analysis of ninety-four cases. Cancer 1967, 20:2090-2099.
152. Vuitch MF, Rosen PP, Erlandson RA Pseudoangiomatous hyperplasia of mammary stroma. Hum Pathol 1986, 17:185-191.
153. Dupont WD, Page DL, Parl FF, et al. Long-term risk of breast cancer in women with fibroadenoma. N Engl J Med 1994, 331:10-15.
154. Demetrakoloulos NJ Three-dimensional reconstruction of a human mammary fibroadenoma. Quarterly Bulletin of Northwestern University Medical School 1958, 32:221-228.
155. Dupont WD, Page DL, Parl FF, et al. Long-term risk of breast cancer in women with fibroadenoma. N Engl J Med 1994, 331:10-15.
156. Fekete P, Petrek J, Majmudar B, et al. Fibroadenoma with stromal cellularity: A clinicopathologic study of 21 patients. Arch Pathol Lab Med 1987, 111:427-432.
157. Foster ME, Garrahan N, Williams S Fibroadenoma of the breast: A clinical and pathological study. J R Coll Surg Edinb 1988, 33:16-19.
158. Oberman HA Breast lesions in the adolescent female. Pathol Annu 1979, 14:175-201.
159. Pike AM, Oberman HA Juvenile (cellular) adenofibromas: A clinicopathologic study. Am J Surg Pathol 1985, 9:730-736.
160. Carney JA, Toorkey BC Myxoid fibroadenoma and allied conditions (myxomatosis) of the breast: A heritable disorder with special associations including cardiac and cutaneous myxomas. Am J Surg Pathol 1991, 15:713-721.
161. Grimes M Cystosarcoma of the breast: Histologic features, flow cytometry analysis, and clinical correlations. Mod Pathol 1992, 5:232-239.
162. Keelan PA, Meyers JL, Wold LE, et al. Phyllodes tumor: Clinicopathologic review of 60 patients and flow cytometric analysis in 30 patients. Hum Pathol 1992, 23:1048-1054.
163. Lu YJ, Birdsall S, Osin P, et al. Phyllodes tumors of the breast analyzed by comparative genomic hybridization and association of increased 1q copy number with stromal overgrowth and recurrence. Genes Chromosomes Cancer 1997, 20:275-281.
164. Noguchi S, Yokouchi H, Aihora T, et al. Progression of fibroadenoma to phyllodes tumor demonstrated by clonal analysis. Cancer 1995, 76:1779-1785.
165. Norris HJ, Taylor HB Relationship of histological features to behavior of cystosarcoma phyllodes: Analysis of ninety-four cases. Cancer 1967, 20:2090-2099.
166. Powell CM, Rosen PP Adipose differentiation in cystosarcoma phyllodes: A study of 14 cases. Am J Surg Pathol 1994, 18:720-727.
167. Reinfuss M, Mitus J, Duda K, et al. The treatment and prognosis of patients with phyllodes tumor of the breast: An analysis of 170 cases. Cancer 1996, 77:910-916.
168. Seijo L, Sidhu J, Mizrachy B, et al. Malignant phyllodes tumor of the breast: A report of four cases with associated fibroadenomata. Int J Surg Pathol 1995, 3:17-22.
169. Ward RM, Evans HL Cystosarcoma phyllodes: A clinicopathologic study of 26 cases. Cancer 1986, 58:2282-2289.
170. Azzopardi JG Problems in Breast Pathology. (Major Problems in Pathology, vol 11.) 1979, WB Saunders, London.
171. Arrigoni MG, Dockerty MB, Judd ES The identification and treatment of mammary hamartoma. Surg Gynecol Obstet 1971, 133:577-582.
172. Azzopardi JG Problems in Breast Pathology. (Major Problems in Pathology, vol 11.) 1979, WB Saunders, London.
173. Daya D, Trus T, D'Souza TJ, et al. Hamartoma of the breast, an underrecognized breast lesion: A clinicopathologic and radiographic study of 25 cases. Am J Clin Pathol 1995, 103:685-689.
174. Fisher CJ, Hanby AM, Robinson L, et al. Mammary hamartoma: A review of 35 cases. Histopathology 1992, 20:99-106.
175. Jones MW, Norris HJ, Wargotz ES Hamartomas of the breast. Surg Gynecol Obstet 1991, 173:54-56.
176. Linell F, Ostberg G, Soderstrom J, et al. Breast hamartomas: An important entity in mammary pathology. Virchows Arch [A] 1979, 383:253-264.
177. Oberman HA Hamartomas and hamartoma variants of the breast. Semin Diagn Pathol 1989, 6:135-145.
178. Ibrahim RE, Sciotto CG, Weidner N Pseudoangiomatous hyperplasia of mammary stroma: Some observations regarding its clinicopathologic spectrum. Cancer 1989, 63:1154-1160.
179. Powell CM, Cranor ML, Rosen PP Pseudoangiomatous stromal hyperplasia (PASH): A mammary stromal tumor with myofibroblastic differentiation. Am J Surg Pathol 1995, 19:270-277.
180. Vuitch MF, Rosen PP, Erlandson RA Pseudoangiomatous hyperplasia of mammary stroma. Hum Pathol 1986, 17:185-191.